Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease
This study is currently recruiting participants.
Verified by National Heart, Lung, and Blood Institute (NHLBI), December 2008
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00807482
  Purpose

The overall short-term goals of this project include the following: 1) identify the genes that are key to the function of respiratory cilia to protect the normal lung; and 2) the effects of genetic mutations that adversely affect ciliary function and cause primary ciliary dyskinesia (PCD), which results in life-shortening lung disease. The long-term goal of this project is to develop better understanding of the underlying genetic variability that adversely modifies ciliary function, and predisposes to common airway diseases, such as asthma and chronic obstructive pulmonary disease.


Condition
Kartagener Syndrome

U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Pathogenesis of PCD Lung Disease

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Blood samples, buckle scrape, semen, and scrape biopsy of nasal cells


Estimated Enrollment: 250
Study Start Date: January 2004
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
People who have been definitively diagnosed with primary ciliary dyskinesia (PCD).

Detailed Description:

A key component of lung defense is the efficiency of mucociliary clearance (MCC).

Primary ciliary dyskinesia (PCD) is a human genetic disorder with defective MCC. This ongoing project is designed to identify additional disease-causing mutations in PCD, and correlate the molecular etiologies with the ciliary phenotype (ultrastructure, wave form and beat frequency). We have recently shown that the normal human cilium has a distinctive waveform, i.e. beats in-plane with defined curvatures and amplitudes for the effective (forward) and recovery stroke. We hypothesize that discrete sets of genes contribute to the structure and function of the ciliary outer dynein arm (ODA), inner dynein arm (IDA), and central pair (CP) and radial spoke (RS) complex (CP/RS), and that we can identify novel genetic mutations in different structural components of the cilium that will have different effects on ciliary ultrastructure, wave form, and beat frequency. Importantly, we are now able to identify patients with PCD who do not have hallmark diagnostic ultrastructural defects, based on distinctive clinical phenotypes (including situs inversus), low or borderline nasal NO production, and abnormal ciliary motility. Identification of PCD patients with normal ciliary ultrastructure (~16% of PCD patients at UNC) offers the opportunity to discover mutations in genes that cause functional, but not ultrastructural, defects (such as DNAH11), and to correlate those mutations with ciliary waveform abnormalities. Over the past 4 years, we have made great progress in identifying mutations in 2 genes (DNAI1 and DNAH5) that cause ~60% of ODA defects in PCD, and ~35% of PCD overall. We will extend our search for disease causing mutations in PCD, using several different approaches, including studies of additional candidate genes, (guided by ultrastructure), plus insights from ciliary proteomics, and family-based studies. Taken together, these studies will provide new insights regarding the relationship of mutations in specific genes to ciliary ultrastructural and functional defects. These studies will not only greatly enhance our ability to diagnose PCD, but will also lead to discovery of "milder" genetic mutations associated with normal ciliary ultrastructure, and likely some residual ciliary function. Ultimately, this will allow future studies of the role of partial loss of ciliary function in the predisposition to more common airways diseases, such as chronic bronchitis and chronic obstructive pulmonary disease.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Patients who have a high suspicion for the diagnosis of PCD, based on clinical features.

Criteria

Inclusion Criteria:

  • Patients who have a high suspicion for the diagnosis of PCD, based on clinical features
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00807482

Locations
United States, North Carolina
The University of North Carolina at Chapel Hill Recruiting
Chapel Hill, North Carolina, United States, 27599
Contact: Michael R. Knowles, MD     919-966-6780     knowles@med.unc.edu    
Contact: Beth Godwin, BA     919-966-6780     godwine@med.unc.edu    
Sponsors and Collaborators
Investigators
Principal Investigator: Michael R. Knowles, MD The University of North Carolina at Chapel Hill
  More Information

Click here for the University of North Carolina PCD Research Web site.  This link exits the ClinicalTrials.gov site

Publications of Results:
Zariwala MA, Leigh MW, Ceppa F, Kennedy MP, Noone PG, Carson JL, Hazucha MJ, Lori A, Horvath J, Olbrich H, Loges NT, Bridoux AM, Pennarun G, Duriez B, Escudier E, Mitchison HM, Chodhari R, Chung EM, Morgan LC, de Iongh RU, Rutland J, Pradal U, Omran H, Amselem S, Knowles MR. Mutations of DNAI1 in primary ciliary dyskinesia: evidence of founder effect in a common mutation. Am J Respir Crit Care Med. 2006 Oct 15;174(8):858-66. Epub 2006 Jul 20.
Hornef N, Olbrich H, Horvath J, Zariwala MA, Fliegauf M, Loges NT, Wildhaber J, Noone PG, Kennedy M, Antonarakis SE, Blouin JL, Bartoloni L, Nusslein T, Ahrens P, Griese M, Kuhl H, Sudbrak R, Knowles MR, Reinhardt R, Omran H. DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Am J Respir Crit Care Med. 2006 Jul 15;174(2):120-6. Epub 2006 Apr 20.
Kennedy MP, Noone PG, Leigh MW, Zariwala MA, Minnix SL, Knowles MR, Molina PL. High-resolution CT of patients with primary ciliary dyskinesia. AJR Am J Roentgenol. 2007 May;188(5):1232-8.
Kennedy MP, Omran H, Leigh MW, Dell S, Morgan L, Molina PL, Robinson BV, Minnix SL, Olbrich H, Severin T, Ahrens P, Lange L, Morillas HN, Noone PG, Zariwala MA, Knowles MR. Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia. Circulation. 2007 Jun 5;115(22):2814-21. Epub 2007 May 21.
Zariwala MA, Knowles MR, Omran H. Genetic defects in ciliary structure and function. Annu Rev Physiol. 2007;69:423-50. Review.

Responsible Party: The University of North Carolina at Chapel Hill ( Michael R. Knowles, MD )
Study ID Numbers: 572, 5 R01 HL071798
Study First Received: December 11, 2008
Last Updated: December 29, 2008
ClinicalTrials.gov Identifier: NCT00807482  
Health Authority: United States: Federal Government

Keywords provided by National Heart, Lung, and Blood Institute (NHLBI):
Primary Ciliary Dyskinesia
Mucociliary Clearance
Genetic Mutation

Study placed in the following topic categories:
Otorhinolaryngologic Diseases
Heart Diseases
Primary ciliary dyskinesia
Cardiovascular Abnormalities
Bronchiectasis
Situs Inversus
Dyskinesias
Kartagener Syndrome
Dextrocardia
Kartagener syndrome
Situs inversus viscerum
Genetic Diseases, Inborn
Respiratory Tract Diseases
Lung Diseases
Ciliary Motility Disorders
Congenital Abnormalities
Heart Defects, Congenital

Additional relevant MeSH terms:
Respiratory System Abnormalities
Pathologic Processes
Disease
Bronchial Diseases
Syndrome
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009